Yama Akbari
· Associate Professor of Neurology; Anatomy and Neurobiology; Neurological SurgeryVerifiedUniversity of California, Irvine · Political Science
Active 2000–2026
About
Yama Akbari is a critical care neurologist and neuroscientist who holds the position of tenured Associate Professor at UC Irvine, with appointments in Neurology, Neurological Surgery, Anatomy & Neurobiology, and the Beckman Laser Institute & Medical Clinic. His research focuses on understanding consciousness, coma, and cardiac arrest/resuscitation, with additional interests in stroke and traumatic brain injury. He is a physician-scientist who balances clinical duties in the Neuro-Intensive Care Unit at UC Irvine Medical Center with leading a basic science and translational research lab. His lab investigates cerebral hemodynamics, brain metabolism, and connectivity during hyperdynamic perfusion states such as cardiac arrest and resuscitation, utilizing multimodal monitoring and advanced optical imaging techniques. Akbari's work aims to improve understanding of brain function during acute injury and to enhance resuscitation strategies to protect the brain. He obtained his BS in psychobiology from UCLA, followed by an MD/PhD from UC Irvine, and completed neurology residency at UCLA and a neurocritical care fellowship at Johns Hopkins University. Since returning to UC Irvine in 2012, he established the university’s first cardiac arrest and resuscitation laboratory, fostering collaborations with the Beckman Laser Institute to develop innovative imaging platforms. In addition to his research, he is actively involved in teaching students, residents, and fellows, and has received numerous awards for his contributions to research and mentorship.
Research topics
- Medicine
- Psychology
- Neuroscience
- Intensive care medicine
- Pathology
- Internal medicine
- Engineering
- Psychiatry
- Engineering ethics
- Nuclear medicine
- Radiology
- Emergency medicine
- Surgery
Selected publications
Mendeley Data · 2026-04-20
datasetOpen accessSenior authorEleven patients with occlusion of the middle cerebral artery and/or the internal carotid artery were monitored intraoperatively during endovascular thrombectomy using a time-domain near-infrared spectroscopy system (Hamamatsu's TRS-21). This dataset presents absolute concentrations of oxyhemoglobin ([HbO2]), deoxyhemoglobin ([HHb]), total hemoglobin ([tHb]), and tissue oxygen saturation (StO2) on both hemispheres of the brain, which were derived using a transport-rigorous scaled Monte Carlo approach. Demographics of the cohort, intraoperative vitals, and neuroimaging (computed tomography, magnetic resonance imaging, and fluoroscopy) are also presented for the cohort.
medRxiv · 2026-04-29
articleSenior authorAbstract Background Existing neuromonitoring tools lack the capability for continuous, intraoperative assessment of cerebral oxygenation and tissue viability during endovascular thrombectomy (EVT) of large vessel occlusion stroke. Time-domain near-infrared spectroscopy (TD-NIRS), an advanced non-invasive optical technique, may overcome this challenge. However, no study has yet investigated TD-NIRS’ feasibility as an intraoperative neuromonitoring tool during EVT and its capability in predicting post-recanalization infarct. Methods In this prospective observational study, eleven patients with middle cerebral artery or internal carotid artery occlusion were monitored during EVT using TD-NIRS. Absolute concentrations of oxyhemoglobin ([HbO 2 ]), deoxyhemoglobin ([HHb]), total hemoglobin ([tHb]), and tissue oxygen saturation (StO 2 ) on both hemispheres was derived using a scaled Monte Carlo approach. Patients were dichotomized into post-EVT cortical infarct and no infarct, and the Δ[HbO 2 ]/[HHb] pre- vs post-recanalization was assessed. Results Significant differences were observed in pre- vs post-recanalization [HbO 2 ] ( p =0.0068), [HHb] ( p =0.042), and StO 2 ( p =0.0020) on the affected hemisphere. The Δ[HbO 2 ]/[HHb] significantly differed between patients with and without post-EVT infarct ( p =0.0043). Logistic regression ( p =0.0041) and ROC (AUC=0.82) determined that Δ[HbO 2 ]/[HHb] reliably predicts post-EVT cortical infarct. Conclusions These results suggest TD-NIRS as a novel, adjunctive intraoperative neuromonitoring tool during EVT, with potential to predict post-EVT cortical infarct, guiding clinical management before/after thrombectomy. Graphical Abstract
Neuron · 2026-05-01
articleMendeley Data · 2026-04-20
datasetOpen accessSenior authorEleven patients with occlusion of the middle cerebral artery and/or the internal carotid artery were monitored intraoperatively during endovascular thrombectomy using a time-domain near-infrared spectroscopy system (Hamamatsu's TRS-21). This dataset presents absolute concentrations of oxyhemoglobin ([HbO2]), deoxyhemoglobin ([HHb]), total hemoglobin ([tHb]), and tissue oxygen saturation (StO2) on both hemispheres of the brain, which were derived using a transport-rigorous scaled Monte Carlo approach. Demographics of the cohort, intraoperative vitals, and neuroimaging (computed tomography, magnetic resonance imaging, and fluoroscopy) are also presented for the cohort.
Neurology · 2025-04-07
articleTo evaluate predictive performance of quantitative electroencephalogram (qEEG) features in predicting outcomes among moderate-severe traumatic brain injury (msTBI) patients.
What is the Philosophy of Neurology? Scoping Review and Defining the Discipline (P2-1.016)
Neurology · 2025-04-07
articleTo chart a course for a new sub-discipline, the philosophy of neurology, informed by existing empirical literature in neurology with reciprocal influence for clinical care and philosophical topics.
Cerebrovascular alterations in a mouse model of late-onset Alzheimer’s disease
Neurophotonics · 2025-06-05 · 1 citations
articleOpen accessSignificanceAlzheimer’s disease (AD) is an age-related neurodegenerative disorder with cerebrovascular alterations contributing to cognitive decline. Assessing cerebrovascular changes in mouse models that mimic the human condition of late-onset, sporadic AD is important for better human applicability.AimTo assess cerebrovascular changes in three mouse models: (1) 3xTg-AD; (2) the humanized amyloid-beta knock-in (hAβ-KI) mouse model of late-onset, sporadic AD; and (3) age-matched wild-type mice.ApproachWe measured resting-state cerebral blood flow (CBF) and neurovascular coupling (NVC) using laser speckle imaging (LSI) and performed ex vivo analyses of gene expression and cerebrovascular structure using bulk ribonucleic acid sequencing and confocal microscopy, respectively.ResultsOur study identifies specific cerebrovascular alterations in the hAβ-KI mouse model, including increased resting-state CBF, a shift toward smaller blood vessel diameters, impaired NVC, and transcriptomic changes related to metabolism and inflammation. Notably, we found that the increased resting-state CBF was primarily associated with female hAβ-KI mice.ConclusionsOur findings demonstrate that the hAβ-KI mouse model exhibits cerebrovascular alterations that warrant further investigation to uncover the underlying mechanisms. Expanding these studies could enhance our understanding of cerebrovascular alterations in AD and support the development of targeted therapeutic strategies.
Antipsychotic Practice Patterns and Clinical Outcomes in Moderate-to-severe TBI (P10-7.005)
Neurology · 2025-04-07
articleIn this study, we sought to assess the pattern of antipsychotics used for moderate-severe TBI (msTBI) and their relationship to functional outcomes.
Journal of Intensive Care Medicine · 2025-07-13 · 2 citations
reviewOpen accessBACKGROUND: Hypoxic-ischemic brain injury (HIBI) is a significant cause of disability following cardiac arrest (CA). Activation of the inflammatory cascade is central to HIBI pathophysiology and drives post-cardiac arrest syndrome (PCAS), which can induce further secondary brain injury. Although numerous studies have described this mechanism in preclinical models, translating this knowledge to therapeutic targets and neurological outcomes in humans is variable and incomplete. The impact of inflammation on the neurovascular unit, comprising neurons, astroglia, and capillary endothelium, may play a significant role in outcomes but is poorly understood in humans. OBJECTIVE: This narrative review explores studies examining PCAS, inflammation, and neurological outcomes in adult CA and classifies them into interrelated pathomechanisms. METHODS: We searched multiple databases using a search string constructed from core concepts, including inflammation, CA, neurovascular unit components, and neurologic outcomes. We screened abstracts published from database conception until July 2024 and excluded animal/in-vitro studies, unrelated topics, duplicates, foreign language articles, reviews/commentaries, studies without neurological outcomes, and case studies. RESULTS: The biomarkers studied fit into three general domains: reperfusion-induced oxidative stress, local and systemic inflammatory response, and coagulopathy associated with endothelial injury. Numerous markers were associated with neurological outcomes after CA, but few demonstrated a strong association in multivariate analysis. Few clinical trials of therapies for CA have studied impacts on the inflammatory cascade or have targeted inflammatory components. Associations between inflammation reduction and neurological outcomes are variable. However, various limitations reduce the applicability of these trials. CONCLUSIONS: Inflammatory mechanisms in PCAS may hold the key to secondary brain injury and warrant larger, more systematic studies to establish therapeutic targets to improve neurological outcomes.
Circulation · 2025-11-03
articleIntroduction/Background: Vascular tone dysregulation is central to cardiovascular pathophysiology. KCNQ (Kv7) potassium channels, primarily heteromeric KCNQ4/5 channels, regulate smooth muscle membrane potential and contractility, yet the specific role of the KCNQ5 subunit in vascular reactivity remains underexplored. The absence of KCNQ5-specific tools has limited mechanistic understanding, particularly regarding receptor-mediated signaling in distinct vascular beds. Research Questions/Hypothesis: We hypothesized that KCNQ5 plays a critical, region-specific role in vascular contractility and receptor-mediated relaxation, particularly to adrenergic stimuli. We aimed to determine whether genetic deletion of KCNQ5 disrupts vasoreactivity and arterial signaling dynamics. Methods/Approach: We generated a CRISPR-based germline KCNQ5 knockout ( Kcnq5 -/- ) rat line. Using in vivo multimodal monitoring (cardiac and brain hemodynamics), ex vivo myography of mesenteric and cerebral arteries, and in vitro electrophysiology of Xenopus oocytes expressing KCNQ4/5/KCNE4 complexes, we analyzed vascular responses to pharmacologic and physiologic stimuli including adrenergic agonists, KCNQ modulators, and the botanical KCNQ5 isoform-selective vasorelaxant aloperine. Results/Data: Kcnq5 -/- rats displayed blunted heart rate, cerebral blood flow, and vasoregulatory responses to hypercapnia and isoflurane, and impaired cerebral vasodilation to aloperine. In contrast, cerebral artery segments mounted in a wire myograph displayed preserved function. In mesenteric artery segments studied using wire myography, deletion of KCNQ5 did not affect basal tone or luminal diameter but impaired relaxation responses to the Kv7 channel opener ML213, aloperine, and the β-adrenergic agonist isoprenaline. Constriction to the α 1 -adrenergic agonist methoxamine was enhanced and showed reduced sensitivity to linopirdine, highlighting KCNQ5’s key role in regulating adrenergic vasoconstriction. Cellular electrophysiology studies delineated PKA/PKC sensitivity of KCNQ5-containing channels. Conclusions: KCNQ5 is essential for receptor-mediated signaling in specific vascular beds. Its deletion enhances α 1 -adrenergic constriction and impairs β-adrenergic and botanical-induced vasorelaxation, highlighting its important functional role. These findings identify KCNQ5 as a key component of Kv7 channel architecture and vasoregulation, which likely varies across vascular beds.
Recent grants
Frequent coauthors
- 34 shared
Afsheen Bazrafkan
- 33 shared
Stephan A. Mayer
Westchester Medical Center
- 31 shared
Tarek Sharshar
FHU Neurovasc
- 30 shared
Brian L. Edlow
Massachusetts General Hospital
- 28 shared
Bernard Choi
Beckman Laser Institute and Medical Clinic
- 27 shared
Raimund Helbok
Johannes Kepler University of Linz
- 27 shared
Daniel Kondziella
Rigshospitalet
- 25 shared
Christian Crouzet
University of California, Irvine
Education
Associate Professor, Neurology
University of California Irvine
Awards & honors
- Faculty Innovation Fellow, UCI Beall Applied Innovation (202…
- Chancellor's Award for Excellence in Undergraduate Research…
- Physicians of Excellence Honoree, Orange County Medical Asso…
- Athalie Clarke Research Associates Dean’s Junior Physician/S…
- Hiruma/Wagner Award (Japan) (2018)
- Resume-aware match score
- Save to shortlist
- AI-drafted outreach
See your match with Yama Akbari
PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.
- Free to start
- No credit card
- 30-second signup